Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03483103
Title Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-PILOT-017006)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Juno Therapeutics, Inc.
Indications

B-cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

Lisocabtagene maraleucel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.